Picture of Sygnis SA logo

SYG Sygnis SA Share Price

0.000.00%
pl flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Momentum

Relative Strength (%)
1m-18.92%
3m-25.98%
6m-41.4%
1yr-65.15%
Volume Change (%)
10d/3m+119.1%
Price vs... (%)
52w High-62.77%
50d MA-19.42%
200d MA-29.16%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-16.32%
Return on Equity-22.36%
Operating Margin-51.36%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Sygnis SA EPS forecast chart

Profile Summary

Sygnis SA is a Poland-based company, which egages in Research and Development (R&D) activities. The Company is active in four segments: Bioconvergence, Nanotechnology, Power Engineering, and New Incremental Technologies. Bioconvergence is a segment in which research is conducted to prevent the shortage of organs for transplants by bioprinting organs and creating bionic models for drug testing. The Nanotechnology segment is focused on using solutions from the field of photoelectron spectroscopy, and critical atomic force microscopy in casual products. The Power Engineering segment is focused on new methods of energy storage for renewable energy and other sources. New Incremental Technologies is focused on the development of solutions regarding 3D printing. The Company cooperates with over 85 specialists such as physicists, mechatronics, chemists, engineers, designers, and sociologists, and is involved in multiple projects.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    August 16th, 2011
    Public Since
    March 16th, 2012
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    pl flag iconWarsaw Stock Exchange
    Shares in Issue
    22,742,930
    Blurred out image of a map
    Address
    ul. Zwirki i Wigury 101, WARSZAWA, 02-089
    Web
    https://sygnis.pl/
    Phone
    +48 226684757
    Auditors
    Progres Biegli Rewidenci Glinkowski Kuligiewicz Spolka Partn

    SYG Share Price Performance

    Upcoming Events for SYG

    Similar to SYG

    Picture of Airway Medix SA logo

    Airway Medix SA

    pl flag iconWarsaw Stock Exchange

    Picture of Bioton SA logo

    Bioton SA

    pl flag iconWarsaw Stock Exchange

    Picture of Braster SA logo

    Braster SA

    pl flag iconWarsaw Stock Exchange

    Picture of Captor Therapeutics SA logo

    Captor Therapeutics SA

    pl flag iconWarsaw Stock Exchange

    Picture of E-Shopping SA logo

    E-Shopping SA

    pl flag iconWarsaw Stock Exchange

    FAQ